Lu et al. reported that anti-osteoporosis treatment could improve bone strength, prevent osteoporosis and rebalance the OPG-RANK-RANKL system, which might help to prevent curve progression in AIS [24]. The gene discussed is TNFRSF11A; the disease is androgen insensitivity syndrome.